Precision medicine aims to match the right treatment to the right patient based on the molecular characteristics of their cancer. PARP inhibitors are one type of targeted therapy that has shown promise in certain breast and ovarian cancers linked to defective DNA repair pathways. However, identifying predictive biomarkers remains an active area of research to optimize patient selection and...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian